Emergency: 9010550550
24/7 Service

Comprehensive Uro-Oncology Care

Robotic, laparoscopic, and open expertise guided by tumour boards

Book Cancer Consult
94%
Margin-Negative
Tumour resections with clear margins
48 hrs
Tumour Board Review
Time from imaging upload to multidisciplinary plan
89%
Functional Preservation
Patients maintaining continence or renal function

When to Consult

  • Blood in urine or unexplained urinary symptoms
  • Elevated PSA or abnormal prostate exam
  • Kidney mass found on ultrasound or CT
  • Recurrent bladder tumours or positive urine cytology
  • Testicular lump or scrotal swelling
  • Family history of urothelial or prostate cancers

Understanding Urology Cancer Surgeries in the Indian Context

Urological cancers are increasingly diagnosed in younger Indian patients due to better screening and shifting lifestyles. Ajuda Hospitals brings together surgeons, oncologists, radiologists, and rehabilitation experts to deliver holistic uro-oncology care. We align with NCCN and AIIMS Delhi protocols while personalising treatment for Hyderabad’s diverse communities.

Timely planning is crucial; our tumour board convenes thrice weekly to review imaging and labs uploaded from Ajuda campuses or partner centres. We provide counselling in Telugu, Hindi, Urdu, and English to address both medical and emotional questions.

When to Consult Our Uro-Oncology Unit

⚠️ Symptoms Demanding Urgent Evaluation

  • ✓ Blood in urine or clots
  • ✓ Rising PSA despite medication
  • ✓ Kidney masses reported on ultrasound or CT
  • ✓ Persistent back or bone pain in men with prostate cancer history

Early intervention improves survival and preserves organ function. We accept referrals from across Telangana and offer teleconsults for distant patients.

Our Diagnostic Approach

Precision Imaging

Multiphasic CT, MRI, and PSMA PET-CT define tumour extent. We provide rapid appointments and share images digitally with the tumour board.

Tissue Confirmation

Fusion-guided biopsies, TURBT, or CT-guided renal biopsies ensure accurate histology. Genomic profiling identifies targeted therapy options.

Tumour Board Decision

Within 48 hours, urology, medical and radiation oncology, pathology, radiology, nephrology, and nutrition collaborate on a personalised plan.

Prehabilitation & Counselling

Cardiology, diabetology, and physiotherapy prepare patients for surgery or systemic therapy. Survivorship coordinators outline expectations for recovery.

Treatment Pathways

Surgical Excellence

Partial and radical nephrectomy, prostatectomy, cystectomy, and lymph node dissections are performed via keyhole, robotic, or open routes depending on complexity.

Integrated Systemic Therapy

Neoadjuvant and adjuvant chemotherapy, immunotherapy, or hormonal regimens follow global evidence. We monitor side-effects closely with supportive care.

Bladder Preservation Strategies

For select patients, trimodality therapy (TURBT + chemo-radiation) preserves the bladder while maintaining oncological outcomes.

Functional Preservation

Nerve-sparing techniques, ileal conduits vs neobladders, and continence rehab ensure quality of life stays central to cancer control.

Rehabilitation & Survivorship

Pelvic floor therapy, stoma care education, nutrition planning, and psycho-oncology services keep recovery on track. WhatsApp groups provide peer support.

Long-Term Surveillance

Structured follow-up schedule includes PSA, cystoscopy, imaging, and lab tests. Rural patients can club scans locally and share results online for review.

What to Expect: Your Care Journey

After diagnostic confirmation, coordinators schedule tumour board review and present the plan to you and your family. Prehab visits cover nutrition, physiotherapy, and financial counselling. Surgery or systemic therapy begins within targeted timelines to minimise anxiety.

Post-surgery, patients recover in monitored units with pain management, early mobilisation, and diet progression. Pelvic floor or swallow therapists get involved early. Discharge includes telehealth follow-ups, warning signs, and emergency contact protocols.

Technology & Innovation

We deploy fusion imaging, intraoperative ultrasound, fluorescence-guided surgery, and high-definition laparoscopy. Our pathology lab offers rapid frozen sections. EMR integration allows remote second opinions and cross-campus care continuity.

Preventing Complications

Cancer treatment can impact kidney function, continence, and sexual health. We mitigate risks with nephron-sparing approaches, ERAS pathways, and dedicated rehab. Oncology dietitians manage nutrition, while psychologists support emotional resilience.

Why Ajuda for Urology Cancer Surgeries?

🧠 Tumour Board Insight

Multidisciplinary opinions delivered within 48 hours ensure decisive action.

🎯 Organ Preservation

Nephron-sparing, nerve-sparing, and bladder preservation keep quality of life intact.

💬 Lifelong Support

Survivorship clinics, nutrition, and mental health ensure thriving beyond treatment.

Take the First Step

Facing a urological cancer? Ajuda Hospitals provides rapid, coordinated care grounded in empathy and excellence. Call 9010550550 or send your reports via WhatsApp to start your personalised uro-oncology journey.

Diagnosis Approach

1

Advanced Imaging

Multiphasic CT, MRI, PSMA PET-CT, or contrast-enhanced ultrasound for staging.

2

Image-Guided Biopsy

Fusion prostate biopsy, CT-guided renal biopsy, and TURBT resections for diagnosis.

3

Molecular & Pathology Review

Genomic profiling, PD-L1, and histopathology by specialised uro-pathologists.

4

Multidisciplinary Tumour Board

Urology, medical oncology, radiation, radiology, pathology, and nephrology co-create the plan.

Treatment Options

Partial or Radical Nephrectomy

Laparoscopic, robotic, or open approaches tailored to tumour stage.

Oncological control >95% for localised disease
3-5 day stay

Radical Prostatectomy

Nerve-sparing laparoscopic/robotic surgery with early continence rehab.

PSA undetectable in 92% at 12 months
48-72 hour admission

Bladder Tumour Management

TURBT with blue light, intravesical therapy, and radical cystectomy with neobladder when needed.

Recurrence reduction with risk-adapted intravesical therapy
Day-care to 7 days based on stage

Retroperitoneal Lymph Node Dissection

For testicular cancer with precise anatomical dissection preserving ejaculation.

Event-free survival >90%
5-day stay

Perioperative Systemic Therapy

Neoadjuvant chemotherapy, immunotherapy, or hormone therapy integrated with surgery.

Increases organ preservation and disease-free survival
Protocol-specific

Rehabilitation & Survivorship

Continence training, sexual health counselling, dietary guidance, and survivorship clinics.

Quality-of-life scores improve by 85%
Structured follow-up for 5 years

Expected Outcomes

Treatment Timeline

Week 1

Surgery and initial recovery

6 Weeks

Pathology review; adjuvant therapy decision

3 Months

Return to routine activity with rehab

12 Months

Disease surveillance scans clear

Success Metrics

  • Clear surgical margins
  • Organ function preserved
  • No evidence of disease on follow-up imaging